The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Immunophenotype of normal vs. myeloma plasma cells: Toward antibody panel specifications for MRD detection in multiple myeloma
Open accessAbstract
In recent years, several studies on large series of multiple myeloma (MM) patients have demonstrated the clinical utility of flow cytometry monitoring of minimal residual disease (flow‐MRD) in bone marrow (BM), for improved assessment of response to therapy and prognostication. However, disturbing levels of variability exist regarding the specific protocols and antibody panels used in individual laboratories. Overall, consensus exists about the utility of combined assessment of CD38 and CD138 for the identification of BM plasma cells (PC); in contrast, more heterogeneous lists of markers are used to further distinguish between normal/reactive PCs and myeloma PCs in the MRD settings. Among the later markers, CD19, CD45, CD27, and CD81, together with CD56, CD117, CD200, and CD307, have emerged as particularly informative; however, no single marker provides enough specificity for clear discrimination between clonal PCs and normal PCs. Accordingly, multivariate analyses of single PCs from large series of normal/reactive vs. myeloma BM samples have shown that combined assessment of CD138 and CD38, together with CD45, CD19, CD56, CD27, CD81, and CD117 would be ideally suited for MRD monitoring in virtually every MM patient. However, the specific antibody clones, fluorochrome conjugates and sources of the individual markers determines its optimal (vs. suboptimal or poor) performance in an eight‐color staining. Assessment of clonality, via additional cytoplasmic immunoglobulin (CyIg) κ vs. CyIgλ evaluation, may contribute to further establish the normal/reactive vs. clonal nature of small suspicious PC populations at high sensitivity levels, provided that enough cells are evaluated. © 2015 International Clinical Cytometry Society
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Tai, Y., Soydan, E., Song, W., Fulciniti, M., Kım, K., Hong, F., Li, X.-F., Burger, P., Rumizen, M., Nahar, S., et al. (2009) · Blood · doi:10.1182/blood-2008-10-183772 · Cited by 73
RetractedCompetence and competition: the challenge of becoming a long-lived plasma cell
Radbruch, A., Muehlinghaus, G., Luger, E. O., Inamine, A., Smith, K. G. C., Dörner, T., & Hiepe, F. (2006) · Nature Reviews Immunology · doi:10.1038/nri1886 · Cited by 1,030
on behalf of the EuroFlow Consortium (EU-FP6, L.-C.-2.-0., van Dongen, J. J. M., Lhermitte, L., Böttcher, S., Almeida, J., van der Velden, V. H. J., Flores-Montero, J., Rawstron, A., Asnafi, V, Lécrevisse, Q., et al. (2012) · Leukemia · doi:10.1038/leu.2012.120 · Cited by 934
Self-citationEuroFlow standardization of flow cytometer instrument settings and immunophenotyping protocols
on behalf of the EuroFlow Consortium (EU-FP6, L.-C.-2.-0., Kalina, T., Flores-Montero, J., van der Velden, V. H. J., Martin-Ayuso, M., Böttcher, S., Ritgen, M., Almeida, J., Lhermitte, L., Asnafi, V, et al. (2012) · Leukemia · doi:10.1038/leu.2012.122 · Cited by 783
Self-citationAnderson, K., Bates, M., Slaughenhoupt, B., Pinkus, G., Schlossman, S., & Nadler, L. (1984) · Blood · doi:10.1182/blood.v63.6.1424.1424 · Cited by 704
Rawstron, A. C., Orfao, A., Beksac, M., Bezdickova, L., Brooimans, R. A., Bumbea, H., Dalva, K., Fuhler, G., Gratama, J., Hose, D., et al. (2008) · Haematologica · doi:10.3324/haematol.11080 · Cited by 513
Self-citationPaiva, B., Vidriales, M.-B., Cerveró, J., Mateo, G., Pérez, J. J., Montalbán, M. A., Sureda, A., Montejano, L., Gutiérrez, N. C., de Coca, A. G., et al. (2008) · Blood · doi:10.1182/blood-2008-05-159624 · Cited by 477
Self-citationFlow Cytometric Immunophenotypic Analysis of 306 Cases of Multiple Myeloma
Lin, P. Y., Owens, R., Tricot, G. J. K., & Wilson, C. S. (2004) · American Journal of Clinical Pathology · doi:10.1309/74r4-tb90-buwh-27jx · Cited by 454
Rawstron, A. C., Child, J. A., de Tute, R. M., Davies, F. E., Gregory, W. M., Bell, S. E., Szubert, A. J., Navarro-Coy, N., Drayson, M. T., Feyler, S., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.46.2119 · Cited by 415
Self-citationZonder, J. A., Mohrbacher, A. F., Singhal, S., van Rhee, F., Bensinger, W. I., Ding, H., Fry, J., Afar, D. E. H., & Singhal, A. K. (2012) · Blood · doi:10.1182/blood-2011-06-360552 · Cited by 342
A plasmocyte selective monoclonal antibody (B‐B4) recognizes syndecan‐1
Wijdenes, J., Vooijs, W. C., Clément, C., Post, J., Morard, F., Vita, N., Laurent, P., Sun, R., Klein, B., & Dore, J. (1996) · British Journal of Haematology · doi:10.1046/j.1365-2141.1996.d01-1811.x · Cited by 340
Deckert, J., Wetzel, M.-C., Bartle, L. M., Skaletskaya, A., Goldmacher, V. S., Vallée, F., Zhou-Liu, Q., Ferrari, P., Pouzieux, S., Lahoute, C., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-0695 · Cited by 333
Paiva, B., Gutiérrez, N. C., Rosiñol, L., Vídriales, M.-B., Montalbán, M.-Á., Martínez-López, J., Mateos, M.-V., Cibeira, M.-T., Cordón, L., Oriol, A., et al. (2012) · Blood · doi:10.1182/blood-2011-07-370460 · Cited by 300
Self-citationNew criteria for response assessment: role of minimal residual disease in multiple myeloma
Paiva, B., van Dongen, J. J. M., & Orfao, A. (2015) · Blood · doi:10.1182/blood-2014-11-568907 · Cited by 299
Self-citationLonial, S., Vij, R., Harousseau, J.-L., Facon, T., Moreau, P., Mazumder, A., Kaufman, J. L., Leleu, X., Tsao, L. C., Westland, C., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.37.2649 · Cited by 296
Human peripheral blood B‐cell compartments: A crossroad in B‐cell traffic
Perez‐Andres, M., Paiva, B., Nieto, W. G., Caraux, A., Schmitz, A., Almeida, J., Vogt, R. F., Marti, G. E., Rawstron, A. C., Van Zelm, M. C., et al. (2010) · Cytometry Part B: Clinical Cytometry · doi:10.1002/cyto.b.20547 · Cited by 270
Self-citationCD38 and CD157: A long journey from activation markers to multifunctional molecules
Quarona, V., Zaccarello, G., Chillemi, A., Brunetti, E., Singh, V. K., Ferrero, E., Funaro, A., Horenstein, A. L., & Malavasi, F. (2013) · Cytometry Part B: Clinical Cytometry · doi:10.1002/cyto.b.21092 · Cited by 267
Roussel, M., Lauwers-Cances, V., Robillard, N., Hulin, C., Leleu, X., Benboubker, L., Marit, G., Moreau, P., Pegourie, B., Caillot, D., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.54.8164 · Cited by 266
Terstappen, L., Johnsen, S., Segers-Nolten, I., & Loken, M. (1990) · Blood · doi:10.1182/blood.v76.9.1739.1739 · Cited by 259
Caraux, A., Klein, B., Paiva, B., Bret, C., Schmitz, A., Fuhler, G. M., Bos, N. A., Johnsen, H. E., Orfao, A., Perez-Andres, M., et al. (2010) · Haematologica · doi:10.3324/haematol.2009.018689 · Cited by 255
Self-citationOcio, E. M., Richardson, P. G., Rajkumar, S. V., Palumbo, A., Mateos, M. V., Orlowski, R., Kumar, S., Usmani, S., Roodman, D., Niesvizky, R., et al. (2014) · Leukemia · doi:10.1038/leu.2013.350 · Cited by 233
Paiva, B., Martinez-Lopez, J., Vidriales, M.-B., Mateos, M.-V., Montalban, M.-A., Fernandez-Redondo, E., Alonso, L., Oriol, A., Teruel, A.-I., de Paz, R., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.33.1967 · Cited by 233
Self-citationRawstron, A. C., Davies, F. E., DasGupta, R., Ashcroft, A. J., Patmore, R., Drayson, M. T., Owen, R. G., Jack, A. S., Child, J. A., & Morgan, G. J. (2002) · Blood · doi:10.1182/blood-2001-12-0297 · Cited by 210
Mateo, G., Montalbán, M. A., Vidriales, M.-B., Lahuerta, J. J., Mateos, M. V., Gutiérrez, N., Rosiñol, L., Montejano, L., Bladé, J., Martínez, R., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.4120 · Cited by 208
Self-citationPaiva, B., Almeida, J., Pérez‐Andrés, M., Mateo, G., López, A., Rasillo, A., Vídriales, M., López‐Berges, M., Miguel, J. F. S., & Orfao, A. (2010) · Cytometry Part B: Clinical Cytometry · doi:10.1002/cyto.b.20512 · Cited by 203
Self-citationOptimizing a Multicolor Immunophenotyping Assay
Mahnke, Y. D., & Roederer, M. (2007) · Clinics in Laboratory Medicine · doi:10.1016/j.cll.2007.05.002 · Cited by 202
Hatano, K., Kikuchi, J., Takatoku, M., Shimizu, R., Wada, T., Ueda, M., Nobuyoshi, M., Oh, I., Sato, K., Suzuki, T., et al. (2009) · Oncogene · doi:10.1038/onc.2008.385 · Cited by 191
Sarasquete, M. E., García‐Sánz, R., González, D., Martínez‐López, J., Mateo, G., Martı́nez, P., Ribera, J., Hernández, J. M., Lahuerta, J. J., Órfão, A., et al. (2005) · PubMed · Cited by 181
Puig, N., Sarasquete, M. E., Balanzategui, A., Martínez, J., Paiva, B., García, H., Fumero, S., Jiménez, C., Alcoceba, M., Chillón, M. C., et al. (2014) · Leukemia · doi:10.1038/leu.2013.217 · Cited by 170
Self-citationBarrena, S., Almeida, J., Yunta, M., López, A., Fernández-Mosteirín, N., Giralt, M., Romero, M., Perdiguer, L., Delgado, M., Orfao, A., et al. (2005) · Leukemia · doi:10.1038/sj.leu.2403822 · Cited by 165
Self-citationSan Miguel, J. F., Almeida, J., Mateo, G., Bladé, J., López-Berges, C., Caballero, D., Hernández, J., Moro, M. J., Fernández-Calvo, J., Dı́az-Mediavilla, J., et al. (2002) · Blood · doi:10.1182/blood.v99.5.1853 · Cited by 160
Self-citationOverview of clinical flow cytometry data analysis: recent advances and future challenges
Pedreira, C. E., da Costa, E. S., Lécrevisse, Q., van Dongen, J. J. M., & Órfão, A. (2013) · Trends in biotechnology · doi:10.1016/j.tibtech.2013.04.008 · Cited by 156
Alapat, D. V., Coviello‐Malle, J. M., Owens, R., Qu, P., Barlogie, B., Shaughnessy, J. D., & Lorsbach, R. B. (2011) · American Journal of Clinical Pathology · doi:10.1309/ajcp59uorcyzevqo · Cited by 140
The myeloma cell antigen syndecan‐1 is lost by apoptotic myeloma cells
Jourdan, M., Ferlin, M., Legouffe, É., Horváthová, M., Liautard, J., Rossi, J. F., Wijdenes, J., Brochier, J., & Klein, B. (1998) · British Journal of Haematology · doi:10.1046/j.1365-2141.1998.00623.x · Cited by 134
da Costa, E. S., Pedreira, C. E., Bárrena, S., Lécrevisse, Q., Flores-Montero, J. A., Quijano, S., Almeida, J., García-Macías, M. D. C., Böttcher, S., van Dongen, J. J. M., et al. (2010) · Leukemia · doi:10.1038/leu.2010.160 · Cited by 131
Self-citationCell Surface Markers in Multiple Myeloma
Ruiz-Argüelles, G. J., & Miguel, J. F. S. (1994) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(12)61350-0 · Cited by 119
Veillette, A., & Guo, H. (2013) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2013.04.003 · Cited by 116
FcRL5 as a Target of Antibody–Drug Conjugates for the Treatment of Multiple Myeloma
Elkins, K., Zheng, B., Go, M., Slaga, D., Du, C., Scales, S. J., Yu, S., McBride, J., Tute, R. M. D., Rawstron, A. C., et al. (2012) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-12-0087 · Cited by 97
Minimal residual disease testing in multiple myeloma by flow cytometry: major heterogeneity
Flanders, A. W., Stetler‐Stevenson, M., & Landgren, O. (2013) · Blood · doi:10.1182/blood-2013-05-506170 · Cited by 92
Expression of the CD117 antigen (C‐Kit) on normal and myelomatous plasma cells
Ocqueteau, M. E., Orfao, A., García‐Sánz, R., Almeida, J., González, M., & Miguel, J. F. S. (1996) · British Journal of Haematology · doi:10.1111/j.1365-2141.1996.tb08993.x · Cited by 90
Self-citationImmunophenotype of Normal and Myelomatous Plasma-Cell Subsets
Robillard, N., Wuillème, S., Moreau, P., et al. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00137 · Cited by 86
Paiva, B., Gutiérrez, N.-C., Chen, X., Vídriales, M., Montalbán, M.-Á., Rosiñol, L., Oriol, A., Martínez‐López, J., Mateos, M., López‐Corral, L., et al. (2012) · Leukemia · doi:10.1038/leu.2012.42 · Cited by 83
Self-citationMcLaughlin, B. E., Baumgarth, N., Bigos, M., Roederer, M., Rosa, S. C. D., Altman, J. D., Nixon, D. F., Ottinger, J. S., Oxford, C. L., Evans, T. G., et al. (2008) · Cytometry Part A · doi:10.1002/cyto.a.20555 · Cited by 76
Ise, T., Nagata, S., Kreitman, R. J., Wilson, W. H., Wayne, A. S., Stetler‐Stevenson, M., Bishop, M. R., Scheinberg, D., Rassenti, L. Z., Kipps, T. J., et al. (2006) · Leukemia · doi:10.1038/sj.leu.2404445 · Cited by 67
Cannizzo, E., Bellio, E., Sohani, A. R., Hasserjian, R. P., Ferry, J. A., Dorn, M. E., Sadowski, C., Bucci, J. J., Carulli, G., & Preffer, F. I. (2010) · Cytometry Part B Clinical Cytometry · doi:10.1002/cyto.b.20517 · Cited by 65
Flow Cytometric Immunophenotyping and Minimal Residual Disease Analysis in Multiple Myeloma
Gupta, R., Bhaskar, A., Kumar, L., Sharma, A., & Jain, P. (2009) · American Journal of Clinical Pathology · doi:10.1309/ajcp1gyi7ehqyuyk · Cited by 62
Interactions of syndecan-1 and heparin with human collagens
Antonio, J. D. S., Karnovsky, M. J., Gay, S., Sanderson, R. D., & Lander, A. D. (1994) · Glycobiology · doi:10.1093/glycob/4.3.327 · Cited by 62
3Immunophenotype and DNA cell content in multiple myeloma
Miguel, J. F. S., García‐Sánz, R., González, M., & Órfão, A. (1995) · Baillière s Clinical Haematology · doi:10.1016/s0950-3536(05)80257-4 · Cited by 61
Landgren, O., Gormley, N. J., Turley, D. M., Owen, R. G., Rawstron, A. C., Paiva, B., Barnett, D. B., Arroz, M. J., Wallace, P. K., Durie, B. G. M., et al. (2014) · American Journal of Hematology · doi:10.1002/ajh.23831 · Cited by 56
Self-citationPaiva, B., Chandia, M., Puig, N., Vídriales, M., Perez, J. J., López‐Corral, L., Ocio, E. M., García‐Sánz, R., Gutierrez, N. C., Ubieto, A. J., et al. (2014) · Haematologica · doi:10.3324/haematol.2014.115162 · Cited by 54
Self-citationThe development of potential antibody-based therapies for myeloma
Sherbenou, D. W., Behrens, C. R., Yang, S., Wolf, J. L., Martin, T. G., & Liu, B. (2014) · Blood Reviews · doi:10.1016/j.blre.2014.09.011 · Cited by 39
Potential role of daratumumab in the treatment of multiple myeloma
Mark, T. M., & Khagi, Y. (2014) · OncoTargets and Therapy · doi:10.2147/ott.s49480 · Cited by 34
Campana, D., Suzuki, T., Todisco, E., & Kitanaka, A. (2000) · KARGER eBooks · doi:10.1159/000058768 · Cited by 29
Heparan Sulfate Regulates Targeting of Syndecan-1 to a Functional Domain on the Cell Surface
Yang, Y., Børset, M., Langford, J. K., & Sanderson, R. D. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209440200 · Cited by 28
Quijano, S., López, A., Rasillo, A., Bárrena, S., Sánchez, M. L., Flores-Montero, J. A., Fernández, C., Sayagués, J. M., Osuna, C. S., Fernández, N. S., et al. (2008) · Blood · doi:10.1182/blood-2007-10-119289 · Cited by 26
Self-citationPojero, F., Casuccio, A., Parrino, M. F., Cardinale, G., Romano, G. C., Caruso, C., & Gervasi, F. (2014) · Cytometry Part B Clinical Cytometry · doi:10.1002/cyto.b.21218 · Cited by 21
Iqbal, M. S., Otsuyama, K., Shamsasenjan, K., Asaoku, H., Mahmoud, M. S., Gondo, T., & Kawano, M. (2009) · European Journal Of Haematology · doi:10.1111/j.1600-0609.2009.01284.x · Cited by 13
Cited by
Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition)
Cossarizza, A., Chang, H., Radbruch, A., Acs, A., Adam, D., Adam‐Klages, S., Agace, W. W., Aghaeepour, N., Akdis, M., Allez, M., et al. (2019) · European Journal of Immunology · doi:10.1002/eji.201970107 · Cited by 979
Self-citationFlores-Montero, J., Sanoja-Flores, L., Paiva, B., Puig, N., García-Sánchez, O., Böttcher, S., van der Velden, V. H. J., Pérez-Morán, J.-J., Vidriales, M.-B., García-Sanz, R., et al. (2017) · Leukemia · doi:10.1038/leu.2017.29 · Cited by 676
Self-citationGuidelines for the use of flow cytometry and cell sorting in immunological studies (third edition)
Cossarizza, A., Chang, H., Radbruch, A., Abrignani, S., Addo, R., Akdis, M., Andrä, I., Andreata, F., Annunziato, F., Arranz, E., et al. (2021) · European Journal of Immunology · doi:10.1002/eji.202170126 · Cited by 531
Clinical Applications and Future Directions of Minimal Residual Disease Testing in Multiple Myeloma
Oliva, S., D'Agostino, M., Boccadoro, M., & Larocca, A. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00001 · Cited by 291
Gay, F., Musto, P., Rota-Scalabrini, D., Bertamini, L., Belotti, A., Galli, M., Offidani, M., Zamagni, E., Ledda, A., Grasso, M., et al. (2021) · The Lancet Oncology · doi:10.1016/s1470-2045(21)00535-0 · Cited by 257
Metadata
- Authors
- Flores‐Montero, J., de Tute, R., Paiva, B., Perez, J. J., Böttcher, S., Wind, H., Sanoja, L., Puig, N., Lecrevisse, Q., Vidriales, M. B., van Dongen, J. J. M., & Orfao, A.
- Venue
- Cytometry Part B: Clinical Cytometry
- Publisher
- Wiley
- Published
- 2015-07-31
- Volume
- 90
- Issue
- 1
- Pages
- 61-72
- ISSN
- 1552-4949 (ISSN-L)
- 1552-4957
- OpenAlex
- W1907306325
- Cited by
- 261
- References
- 57
- FWCI
- 14.70
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.